|
HDHD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.03440000009947E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.25260000003603E-07 |
| Normal-vs-Stage2 |
1.242800E-01 |
| Normal-vs-Stage3 |
1.08530000542117E-08 |
| Normal-vs-Stage4 |
9.45279965414159E-10 |
| Stage1-vs-Stage2 |
5.456800E-03 |
| Stage1-vs-Stage3 |
7.675600E-02 |
| Stage1-vs-Stage4 |
1.135690E-02 |
| Stage2-vs-Stage3 |
2.027300E-04 |
| Stage2-vs-Stage4 |
2.07379999999091E-05 |
| Stage3-vs-Stage4 |
2.684200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.56199950143809E-10 |
| Normal-vs-AfricanAmerican |
6.776400E-02 |
| Normal-vs-Asian |
3.55069999999902E-05 |
| Caucasian-vs-AfricanAmerican |
5.665800E-02 |
| Caucasian-vs-Asian |
2.945800E-01 |
| AfricanAmerican-vs-Asian |
3.899600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.21250000040263E-07 |
| Normal-vs-Female |
5.03390000017312E-07 |
| Male-vs-Female |
3.699200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.30289999958444E-07 |
| Normal-vs-Age(41-60Yrs) |
1.33739999996774E-06 |
| Normal-vs-Age(61-80Yrs) |
1.82790999999627E-05 |
| Normal-vs-Age(81-100Yrs) |
5.296300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.536000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.934000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.813800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.701000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.324600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.716000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.00199999997219E-06 |
| Classical-VS-Follicular |
1.16899999680342E-08 |
| Classical-VS-Other |
3.141600E-01 |
| Classical-VS-Normal |
9.67099955673234E-10 |
| Tall-VS-Follicular |
1.63158375698913E-12 |
| Tall-VS-Other |
2.404000E-01 |
| Tall-VS-Normal |
7.54951656745106E-15 |
| Follicular-VS-Other |
8.183200E-03 |
| Follicular-VS-Normal |
6.998600E-01 |
| Other-VS-Normal |
5.638500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.85450000000409E-05 |
| Normal-vs-N1 |
2.05829797650381E-11 |
| N0-vs-N1 |
1.54772999999553E-05 |
|
|
